Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

John Gallacher

Director, Dementias Platform UK; Professor of Cognitive Health

  • PhD AFBPsS CPsychol FFPH

I am the PI and Director of the MRC funded Dementias Platform UK (DPUK) and Professor of Cognitive Health at the University of Oxford. I am also PI for the Caerphilly Prospective Study and have developed the study’s focus on ageing and dementia. As member of the UK Biobank Steering Group, I lead on cognitive and psychological assessment. I am a visiting Professor to Imperial College London and Honorary Professor at the University of Hong Kong. I am Chair of the Avon Longitudinal Study of Parents and Children (ALSPAC) Scientific Advisory Board.

Dementias Platform UK    

Dementias Platform UK is a public-private partnership funded by the Medical Research Council. DPUK’s partners – ten universities and six pharmaceutical companies – have joined forces with the aim of accelerating research towards effective treatment for dementia by improving access to data. By bringing together records from over 40 different cohort studies – including brain scans, genetics and clinical records – DPUK is creating the world’s richest source of people data for use in research and drug development for dementia. This free-to-access resource of cohort data is available for use by any bona fide researcher who is interested in investigating dementia, whether based within a university or industry context. DPUK facilitates safe and secure access to this data through its Data Portal, enabling research and analyses at a scale that has not previously been possible for studies into dementia. It wishes to promote scientific research using cohort study data, and has an active programme of experimental medicine.